Table 2.
Gene Symbol | Gene Name | Accession Number | AIA/HA ratio | Benjamini |
---|---|---|---|---|
BCL2 | B-cell CLL/lymphoma 2 | NM_000633.1 | 0.58 | p < 0.001 |
CASP8 | Caspase 8, apoptosis-related cysteine peptidase | X98172.1 | 0.66 | p < 0.001 |
CCL5 | Chemokine (C-C motif) ligand 5 | NM_002985.1 | 0.71 | p < 0.001 |
CD28 | CD28 antigen (Tp44) | NM_006139.1 | 0.61 | p < 0.005 |
CD69 | CD69 antigen (p60, early T-cell activation antigen) | NM_001781.1 | 0.44 | p < 0.001 |
DDIT3 | DNA-damage-inducible transcript 3 | S40706.1 | 0.76 | p < 0.01 |
DNAJB1 | DnaJ (Hsp40) homolog, subfamily B, member 1 | D49547.1 | 0.76 | p < 0.001 |
EGR3 | Early growth response 3 | NM_004430.1 | 0.42 | p < 0.05 |
LCK | Lymphocyte-specific protein tyrosine kinase | NM_005356.2 | 0.58 | p < 0.001 |
CLU | Clusterin | J02908.1 | 1.79 | p < 0.001 |
CTSD | Cathepsin D (lysosomal aspartyl peptidase) | M11233.1 | 1.50 | p < 0.001 |
CTSZ | Cathepsin Z | AF136273.1 | 1.33 | p < 0.05 |
GPX1 | Glutathione peroxidase 1 | M21304.1 | 1.21 | p < 0.05 |
HMOX1 | Heme oxygenase (decycling) 1 | NM_002133.1 | 1.57 | p < 0.001 |
IL10RB | Interleukin 10 receptor, beta | NM_000628.3 | 1.39 | p < 0.001 |
IL1R1 | Interleukin 1 receptor, type I | NM_000877.2 | 1.48 | p < 0.05 |
IL1R2 | Interleukin 1 receptor, type II | U74649.1 | 2.34 | p < 0.001 |
PRDX6 | Peroxiredoxin 6 | NM_004905.1 | 1.23 | p < 0.005 |
PSMD1 | Proteasome (prosome, macropain) 26 S subunit, non-ATPase, 1 | NM_002807.1 | 1.24 | p < 0.001 |
SERPINB2 | Serpin peptidase inhibitor, clade B (ovalbumin), member 2 | J02685.1 | 2.17 | p < 0.005 |
SOD2 | Superoxide dismutase 2, mitochondrial | NM_000636.1 | 1.53 | p < 0.001 |
TIMP1 | TIMP metallopeptidase inhibitor 1 | NM_003254.1 | 1.71 | p < 0.001 |
TIMP2 | TIMP metallopeptidase inhibitor 2 | NM_003255.2 | 1.59 | p < 0.001 |
TNFRSF1A | Tumor necrosis factor receptor superfamily, member 1A | NM_001065.2 | 1.45 | p < 0.001 |
Statistical analysis was carried out with the Mann-Whitney test.